Article 7. State policies on pharmacy
Law 105/2016/QH13 — Luật Dược số 105/2016/QH13
State policies on pharmacy and development of pharmaceutical industry
1. To ensure sufficient and prompt supply of quality drugs at reasonable prices to meet the people’s disease prevention and treatment needs, suit the structure of diseases and meet requirements of national defense and security, epidemic prevention and control and overcoming of consequences of natural disasters and catastrophes, and of rare drugs.
2. To ensure the rational, safe and effective use of drugs; to prioritize the development of clinical pharmacy and pharmacovigilance.
3. To provide incentives for investment in the manufacture of drugs and drug materials, essential drugs, drugs for prevention and control of social diseases, vaccines, biological products, drugs from medicinal materials, traditional drugs and rare drugs; to provide incentives for scientific research in manufacturing technology and bio-technology to manufacture new drugs.
4. For drugs to be purchased with state budget funds, health insurance fund, revenues from medical examination and treatment services and other lawful revenues of public medical establishments, the following provisions shall be complied with:
a/ To refrain from offering bids of imported drugs on the list of imported drugs issued by the Minister of Health based on technical criteria when domestically manufactured drugs satisfy the treatment, price and supply requirements.
To prioritize the purchase of generic drugs and similar biological products that are first manufactured and granted certificates of registration for circulation in Vietnam; drugs from medicinal materials, traditional drugs made from domestic medicinal materials; drugs using pharmaceutical ingredients, adjuvants, capsules or primary packages manufactured by domestic establishments satisfying good manufacturing practices; raw medicinal materials; drugs from medicinal materials and traditional drugs manufactured under national, ministerial or provincial scientific and technological tasks;
b/ To refrain from offering bids of imported medicinal materials on the list issued by the Minister of Health when domestically cultured, cultivated or harvested medicinal materials satisfy the treatment, price and supply requirements.
The Government shall prescribe reasonable prices mentioned at this Point;
c/ To prioritize the purchase of drugs on the list of national products.
5. To facilitate the submission of applications for registration for circulation of generic drugs whose relevant patents will expire soon and of first similar biological products; to priotitize the registration for circulation and grant of import permits for rare drugs and vaccines which have been assessed for prequalification by the World Health Organization.
6. To combine investment from the state budget and other mobilized resources in the development of the manufacture of vaccines, biological products, drugs from medicinal materials, traditional drugs or drugs whose relevant patents will expire soon; culture, cultivation or production of medicinal materials; discovery, conservation and application of science and technology to the research and development of gene sources of precious, rare and endemic medicinal materials.
7. To support and facilitate the discovery, clinical trial and registration for intellectual property rights protection, registration for circulation and inheritance of traditional drugs and drugs from medicinal materials under national, ministerial or provincial scientific and technological projects already tested and accepted; search for exploitation and use of new medicinal materials; export of cultured and cultivated medicinal materials; acclimatization of medicinal materials; rational exploitation of natural medicinal materials; research, survey and investigation into appropriate medicinal material species for culture and cultivation in localities; development of medicinal material culture and cultivation zones; modernization of the production of medicinal materials, drugs from medicinal materials and traditional drugs.
8. To keep secret information in the preparation and processing of and clinical trial data on traditional drugs; to provide reasonable incentives for those who donate precious traditional medicaments to the State; to facilitate the grant of traditional medicine or pharmacy practice certificates to persons whose folk remedies have been recognized by the Ministry of Health.
9. To encourage technology transfer in drug manufacture; to develop the networks of drug circulation and distribution, drugstores and drug preservation and supply toward professionalism, modernity and effectiveness, ensuring timely and sufficient supply of quality drugs to meet the people’s needs; to encourage drugstores and pharmacies to open around the clock.
To provide investment incentives and support for the development of drug suppliers and mobile drug retailers for ethnic minority people and inhabitants in mountainous areas, on islands, and in areas with extremely difficult socio-economic conditions.
10. To mobilize medical establishments in the people’s armed forces to participate in the supply of drugs and culture and cultivation of medicinal materials in order to meet the disease prevention and treatment needs of people in ethnic minority areas and mountainous areas, on islands, and in areas with extremely difficult socio-economic conditions.
11. To raise the quality of human resources in the pharmacy sector; to give priority in pharmacy practice to persons who have obtained pharmacy practice certificates after passing examinations prescribed by the Government.
Article 7, Law 105/2016/QH13